Novartis (NVS) Misses Q4 EPS by 12c

Novartis (NYSE: NVS) reported Q4 EPS of $1.53, $0.12 worse than the analyst estimate of $1.65. Revenue for the quarter came in at $11.42 billion versus the consensus estimate of $11.9 billion.

For earnings history and earnings-related data on Novartis (NVS) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Morgan Stanley Reiterates Overweight Rating on Befesa SA (BFSA:GR), sees a buying opportunity
• BofA Securities Upgrades AptarGroup (ATR) to Buy